As the Associate Vice President, Head of the Global QPPV Office and EU QPPV at Organon, I am dedicated to steering the company’s safety governance and ensuring rigorous compliance with international regulatory standards. Our commitment to patient safety is reflected in the meticulous benefit-risk monitoring and the effective oversight of the global pharmacovigilance system we put in place.With extensive expertise in clinical development safety and pharmacovigilance, I have led the design and implementation of safety and risk management strategies. Advancing women’s health is at the core of my professional mission, driving our collaborative efforts to uphold the highest standards of patient safety.I hold a Doctor of Medicine degree with a specialty in Obstetrics and Gynaecology, supported by over 20 years of experience in global clinical safety and pharmacovigilance. Throughout my career, I have successfully delivered high-priority projects, often involving large, multidisciplinary, and geographically dispersed teams. My passion lies in safeguarding patient safety and contributing meaningfully to the advancement of women’s health.
